These medications are transforming obesity care, but we still dont have clear evidence on how they perform in people over 65, who often have different risks and vulnerabilities, says Kasia Lipska MD, MHS, associate professor of medicine (endocrinology), who is senior author of the study and Chens mentor
Understanding the gap between efficacy in randomized controlled trials and effectiveness in real-world use of GLP-1 RA and DPP-4 therapies in patients with type 2 diabetes
Semaglutide (Wegovy) In the pivotal STEP-1 trial, semaglutide 2.4 mg produced ~14.9% total body weight loss , significantly greater than placebo5
What Titration Actually Means (And Why We Don't Rush It) Every GLP-1 and GLP-1/GIP medication is designed to start low and climb slowly
Take LOMAIRA or prescription phentermine exactly how your healthcare provider tells you